Dados B3 › ELPL3 × SBSP3
ELPL3 × SBSP3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | ELPL3 | SBSP3 | year |
|---|---|---|---|
| ROE | 14.6%! | 0.0% | 2025 |
| ROIC | 14.8% | 14.4% | 2025 |
| ROA | 3.1% | 9.1% | 2025 |
| Gross margin | 19.0% | 37.0% | 2025 |
| EBIT margin | 13.3% | 33.1% | 2025 |
| Net margin | 4.2% | 22.2% | 2025 |
| Net debt/EBITDA | 2.59x | 1.88x | 2025 |
| Current ratio | 0.74x | 1.12x | 2025 |
| Revenue growth (1y) | 8.9% | 5.4% | 2025 |
| Revenue growth (5y CAGR) | 7.6% | 16.4%! | 2025 |
| Piotroski F-Score | 4/9 | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | ELPL3 | SBSP3 | year |
|---|---|---|---|
| P/E | -17.52x | — | 2018 × 2025 |
| P/B | 1.92x | 2.55x | 2018 × 2025 |
| EV/EBITDA | 7.92x | 9.17x | 2018 × 2025 |
| FCF yield | -31.9% | -5.0% | 2018 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:12 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:12 UTC. If this does not match /saude, you are reading a cached copy.